Articles From: QEP Resources Announces Fourth Quarter and Full Year 2014 Financial and Operational Results Release Date and Conference Call to QLogic and Broadcom First to Demonstrate End-to-End Interoperability for 25Gb and 100Gb Ethernet


2014/12/4
QEP Resources, Inc. (NYSE: QEP)(“QEP” or the “Company”) today announced that members of the Company’s senior management will participate in the upcoming Capital One Securities, Inc. Energy Conference on Wednesday, December 10, 2014 at 2:20 p.m. ET (12:20 p.m. MT). A link to the webcast and a copy of the presentation will be available at www.qepres.com .
Sign-up for QEP Resources Announces Participation in an Upcoming Investor Conference investment picks
2014/12/2
QEP Resources, Inc. (NYSE: QEP)(“QEP” or the “Company”) today announced that its wholly owned subsidiary, QEP Field Services Company, has completed the sale of its midstream business, including the Company's ownership interest in QEP Midstream Partners, LP (NYSE:QEPM, “QEPM”), to Tesoro Logistics LP in an all cash transaction valued at $2.5 billion, including $230 million to refinance debt at QEPM.
Sign-up for QEP Resources Completes Sale of Its Midstream Business investment picks
2015/2/24
Full Year 2014 Highlights Delivered record annual Adjusted EBITDA Reported record crude oil production of 17.1 MMBbl, up 68% from 2013 Increased crude oil production to 32% of total natural gas equivalent production, up from 20% in 2013 Acquired Permian Basin oil and gas properties for an aggregate purchase price of $942 million Divested non-core, upstream properties for $788 million Closed the sale of QEP Field Services, including QEP Resources' ownership in QEP Midstream Partners, LP, for approximately $2.5 billion in cash, resulting in a pre-tax gain on sale of approximately $1.8 billion DENVER, Feb.
Sign-up for QEP Resources Reports Fourth Quarter and Full Year 2014 Financial and Operational Results investment picks
2015/2/13
DENVER, Feb.
Sign-up for QEP Resources, Inc. Declares Quarterly Cash Dividend investment picks
2015/1/11
HILDEN , Germany and BEVERLY, Massachusetts , January 11, 2015 /PRNewswire/ -- Enzymatics products used in 80% of all global NGS sequencing reactions Strengthens QIAGEN's universal NGS product offering and strategy to offer complete NGS workflows from sample to insight Adds comprehensive R&D, manufacturing, formulation and analytical capabilities in enzymology Strategic partnership formed with ArcherDX, including technology and distribution rights to proprietary Archer NGS panel technology QIAGEN reaffirms fourth-quarter and full-year 2014 adjusted net sales guidance; charges to be taken related to acquisition and other restructuring activities QIAGEN N.V. (NASDAQ: QGEN, Frankfurt Prime Standard QIA) today announced the acquisition of the Enzyme Solutions Unit of Enzymatics, a world leader in the development, manufacturing, and OEM supply of enzymes essential
Sign-up for QIAGEN Acquires Enzymatics Enzyme Solutions Unit, a Leading Enabler of NGS Applications investment picks
2015/1/12
HILDEN , Germany , January 12, 2015 /PRNewswire/ -- QIAGEN's circulating tumor DNA test is now CE-IVD marked to assess EGFR mutation status in non-small cell lung cancer (NSCLC) patients based on plasma samples therascreen EGFR RGQ Plasma PCR kit helps physicians to identify patients who could benefit from treatment with IRESSA when tumor tissue sample is not evaluable QIAGEN pioneering the use of liquid biopsy-based companion diagnostics as a less-invasive option to complement surgical biopsies for genomic profiling of cancers QIAGEN (NASDAQ: QGEN; Frankfurt , Prime Standard: QIA) announced today the CE-IVD marking of its novel liquid biopsy-based companion diagnostic that analyzes circulating nucleic acids obtained from blood samples to assess an important genomic mutation in patients with non-small cell lung cancer (NSCLC), the most common form of this cancer.
Sign-up for QIAGEN Announces First-ever Regulatory Registration of a Lung Cancer Companion Diagnostic Based on Liquid Biopsies investment picks
2015/2/24
MARCO ISLAND, Florida , and REDWOOD CITY, California , February 24, 2015 /PRNewswire/ -- Allele Frequency Community formed to significantly address need to improve the interpretation of DNA findings on disease-causing gene variants and rare diseases More than 70,000 sets of diverse human exome- and genome-wide variant call datasets spanning over 100 countries of origin already included in new database Opportunity to significantly increase accuracy of genomic findings: Initial results of database show 43% average reduction of false positives in causal variant identification QIAGEN providing secure bioinformatics infrastructure and software for research and clinical labs to contribute and gain insights from Allele Frequency Community A coalition of 13 leading life science and diagnostics organizations today announced the formation of the Allele Frequency Community, a landmark
Sign-up for QIAGEN Collaborates With Allele Frequency Community to Advance Translational Medicine and Clinical Diagnostics investment picks
2015/1/8
HILDEN , Germany and GERMANTOWN, Maryland , January 8, 2015 /PRNewswire/ -- Ongoing growth with 250 new QIAsymphony placements in 2014 Five FDA approvals and clearances achieved in 2014, including artus HSV-1/2 QS-RGQ MDx Kit QIAGEN affirms goal for more than 1,500 cumulative QIAsymphony placements by year-end 2015 and further test menu expansion QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that it had exceeded its goal for 250 new placements of the QIAsymphony modular automation solution in 2014, bringing the total number of cumulative placements to more than 1,250 at year-end.
Sign-up for QIAGEN Exceeds 2014 Goal to Achieve 1,250 Cumulative QIAsymphony System Placements and Expands artus U.S. Test Menu investment picks
2015/1/27
HILDEN , Germany , and GERMANTOWN, Maryland , January 27, 2015 /PRNewswire/ -- QuantiFERON Monitor (QFM ® ) launches in Europe for monitoring immune function Target markets include transplant patients and research in managing immune modulation and suppression Novel diagnostic with significant potential to expand clinical utility and to address unmet medical need in more than 100,000 solid organ transplants a year QFM applies proven QuantiFERON technology to deliver standardized, cost-effective measurement of immune function QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the commercial launch of QuantiFERON Monitor ® (QFM ® ), a novel diagnostic for monitoring immune function.
Sign-up for QIAGEN Introduces QuantiFERON Monitor® for Tracking Immune Function in Solid Organ Transplant Patients and for Research Into Other Applications investment picks
2015/1/16
VENLO, The Netherlands , January 16, 2015 /PRNewswire/ -- QIAGEN N.V. (Nasdaq: QGEN) (Frankfurt: QIA) plans to release its report on results for the fourth quarter and full year 2014 on Wednesday, January 28 , at 22:00 Central European Time (CET) / 16:00 Eastern Time (ET). Also as previously announced, a conference call is planned for Thursday, January 29 , at 15:30 CET / 9:30 ET that will include remarks by Peer M.
Sign-up for QIAGEN N.V. to Report Fourth Quarter and Full-Year 2014 Results investment picks
2015/1/28
VENLO, the Netherlands , January 28, 2015 /PRNewswire/ -- Full-year 2014 results: Adjusted net sales of $1.35 billion (+4% CER); adjusted operating income of $312.5 million ; and adjusted EPS of $1.00 - Adjusted net sales rise 9% CER excluding U.S. HPV products; free cash flow up 15% to $201.4 million for the year Q4 2014 results in line with pre-announcement: Adjusted net sales of $360.8 million (+4% CER), adjusted operating income of $71.6 million ; and adjusted EPS of $0.25 - Adjusted net sales rise 10% CER excluding U.S. HPV products Growth drivers set to deliver above-market growth and lead QIAGEN portfolio transformation in 2015 during last year of significant U.S. HPV headwinds QIAGEN expects to deliver higher 2015 adjusted net sales and earnings at constant exchange rates, but adverse impact from currency movements QIAGEN N.V.
Sign-up for QIAGEN Reports Results for Fourth Quarter and Full-Year 2014 investment picks
2014/12/4
HILDEN , Germany and GERMANTOWN, Maryland , December 4, 2014 /PRNewswire/ -- New molecular diagnostic test detects but does not differentiate all existing strains of Ebola virus Partnership with altona Diagnostics adds to portfolio of QIAGEN products already in use outside the United States by research and clinical laboratories for Ebola diagnostics and research QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it will offer global distribution of the altona Diagnostics RealStar ® Ebolavirus RT-PCR Kit 1.0 after the U.S. Food and Drug Administration amended, on November 26, 2014 to permit authorized distribution and use in US and certain non-US laboratories, an Emergency Use Authorization (EUA) originally issued on November 10, 2014 , for this kit.
Sign-up for QIAGEN to Distribute altona Diagnostic's RealStar® Ebolavirus RT-PCR Kit 1.0, Recently Authorized by the FDA for Emergency Use investment picks
2014/12/11
BEIJING , Dec.
Sign-up for Qihoo 360 Announces Changes to Board of Directors investment picks
2014/12/16
BEIJING , Dec.
Sign-up for Qihoo 360 Announces Strategic Partnership with Coolpad investment picks
2015/2/11
MOSCOW, Feb.
Sign-up for QIWI and MegaFon Announce Strategic Partnership by Launching a Co-Branded Wallet investment picks
2015/2/24
Qlik® , (NASDAQ: QLIK), a leader in data discovery, today announced that its global corporate social responsibility program, Change Our World, has awarded more than 70 grants to organizations worldwide during 2014.
Sign-up for Qlik ‘Change Our World’ Program Celebrates Five Years investment picks
2015/2/19
Qlik® (NASDAQ: QLIK), a leader in data discovery, and JethroData , the fastest SQL-on-Hadoop in the market, today announced a partnership to enable true interactive business intelligence over Hadoop.
Sign-up for Qlik and JerthroData Partner to Deliver Interactive Data Discovery on Hadoop Solutions investment picks
2015/1/6
Qlik, (NASDAQ: QLIK), a leader in data discovery, today announced it will report its fourth quarter and full year 2014 financial results after the U.S. financial markets close on Thursday, February 12, 2015.
Sign-up for Qlik Announces Date of Fourth Quarter and Full Year 2014 Financial Results Release investment picks
2015/2/12
Qlik (NASDAQ: QLIK), a leader in data discovery delivering intuitive solutions for self-service data visualization and guided analytics, today announced financial results for the fourth quarter and full year ended December 31, 2014.
Sign-up for Qlik Announces Fourth Quarter and Full Year 2014 Financial Results investment picks
2015/2/13
Qlik ® (NASDAQ: QLIK), a leader in data discovery, today announced it has acquired Vizubi and its NPrinting product line, the market-leading report generation, distribution, and scheduling application for QlikView ®. A Qlik partner since 2013, NPrinting allows organizations to create visually-appealing reports with drag-and-drop simplicity, in a variety of popular formats including Microsoft Office, PixelPerfect (.PDF), and HTML, using data and analytics from QlikView.
Sign-up for Qlik Bolsters Advanced Reporting Capabilities with Acquisition of NPrinting investment picks
2015/2/24
Qlik® , (NASDAQ: QLIK) a leader in data discovery, today announced it has been positioned by Gartner, Inc. in the Leaders Quadrant of the 2015 Business Intelligence and Analytics Platform Magic Quadrant report*. This designation marks the fifth consecutive year that Qlik has been positioned in the Leaders Quadrant based on completeness of vision and ability to execute.
Sign-up for Qlik Positioned in the Leaders Quadrant of Gartner’s Business Intelligence and Analytics Platforms Magic Quadrant for Fifth Consecutive Year investment picks
2015/1/26
Qlik ® (NASDAQ: QLIK), a leader in data discovery, today announced an extended commitment to the developer and open source communities with the launch of Qlik Branch .
Sign-up for Qlik Sense Platform APIs Ignite New Open Source Community investment picks
2014/12/2
Qlik , (NASDAQ: QLIK), a leader in data discovery, today announced that Chief Executive Officer, Lars Bjork, and Chief Financial Officer, Tim MacCarrick, will present at the Barclays Global Technology Conference in San Francisco on December 9, 2014 at 11:30 a.m. PST.
Sign-up for Qlik to Present at the Barclays Global Technology Conference investment picks
2014/12/5
Qlik , (NASDAQ: QLIK), a leader in data discovery, today announced that Vice President of Innovation and Design, Donald Farmer, will present at the CLSA Innovation Summit in New York City on December 11, 2014 at 11:20 a.m. EST.
Sign-up for Qlik to Present at the CLSA Innovation Summit investment picks
2015/2/24
Qlik , (NASDAQ: QLIK), a leader in data discovery, today announced that Chief Executive Officer, Lars Björk, and Chief Financial Officer, Tim MacCarrick, will present at the following upcoming conferences in March.
Sign-up for Qlik to Present at Upcoming Conferences in March investment picks
2015/1/20
ALISO VIEJO, Calif., Jan.
Sign-up for QLogic 10Gb Ethernet Adapters Accelerate Application Performance by 10X for Health Utility Provider Hart Solution investment picks
2014/12/11
ALISO VIEJO, Calif., Dec.
Sign-up for QLogic 10Gb Ethernet Technology Now Available for Flex System Compute Nodes From Lenovo investment picks
2015/2/6
ALISO VIEJO, Calif., Feb.
Sign-up for QLogic Achieves 11th Consecutive Year of Fibre Channel Leadership investment picks
2015/1/27
ALISO VIEJO, Calif., Jan.
Sign-up for QLogic and Broadcom First to Demonstrate End-to-End Interoperability for 25Gb and 100Gb Ethernet investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: QEP Resources Announces Fourth Quarter and Full Year 2014 Financial and Operational Results Release Date and Conference Call to QLogic and Broadcom First to Demonstrate End-to-End Interoperability for 25Gb and 100Gb Ethernet
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent